The Framingham Heart Study-67 years of discovery in metabolic disease

Nature Reviews Endocrinology

Volumn 12, Issue 3, 2016, Pages 177-183

  Long, Michelle T ^a   Fox, Caroline S ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENTION; BLOOD FLOW VELOCITY; BODY FAT DISTRIBUTION; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COGNITION; COHORT ANALYSIS; CONCEPT FORMATION; FRAMINGHAM RISK SCORE; GENETICS; GROUPS BY AGE; HEREDITY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INTRAABDOMINAL FAT; LEARNING; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SKINFOLD THICKNESS; SUBCUTANEOUS FAT; UNITED STATES; VERBAL MEMORY; WAIST CIRCUMFERENCE; WAIST HIP RATIO; DIABETES MELLITUS, TYPE 2; HEART DISEASES; METABOLIC DISEASES; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE;

COHORT STUDIES; DIABETES MELLITUS, TYPE 2; HEART DISEASES; HUMANS; METABOLIC DISEASES; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84958109289     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2015.226     Document Type: Review

References (65)

1. Kannel, W. B., LeBauer, E. J., Dawber, T. R., & McNamara, P. M. Relation of body weight to development of coronary heart disease. The Framingham study. Circulation 35, 734-744 (1967
2. Wilson, P. W., McGee, D. L., & Kannel, W. B. Obesity, very low density lipoproteins, and glucose intolerance over fourteen years: the Framingham Study. Am. J. Epidemiol. 114, 697-704 (1981
3. Wilson, P. W., Dagostino, R. B., Sullivan, L., Parise, H., & Kannel, W. B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch. Intern. Med. 162, 1867-1872 (2002
4. Kenchaiah, S., et al. Obesity and the risk of heart failure. N. Engl. J. Med. 347, 305-313 (2002
5. Wang, T. J., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292, 2471-2477 (2004
6. Kissebah, A. H., et al. Relation of body fat distribution to metabolic complications of obesity. J. Clin. Endocrinol. Metab. 54, 254-260 (1982
7. Kannel, W. B., et al. Regional obesity and risk of cardiovascular disease; the Framingham Study. J. Clin. Epidemiol. 44, 183-190 (1991
8. Larsson, B., et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br. Med. J. (Clin. Res. Ed) 288, 1401-1404 (1984
9. Britton, K. A., & Fox, C. S. Ectopic fat depots and cardiovascular disease. Circulation 124, e837-e841 (2011
10. Fox, C. S., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation 116, 39-48 (2007
11. Britton, K. A., et al. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J. Am. Coll. Cardiol. 62, 921-925 (2013
12. Rosito, G. A., et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham heart study. Circulation 117, 605-613 (2008
13. Salans, L. B., Knittle, J. L., & Hirsch, J. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J. Clin. Invest. 47, 153-165 (1968
14. Gealekman, O., et al. Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity. Circulation 123, 186-194 (2011
15. Hu, H. H., Chung, S. A., Nayak, K. S., Jackson, H. A., & Gilsanz, V. Differential computed tomographic attenuation of metabolically active and inactive adipose tissues: preliminary findings. J. Comput. Assist. Tomogr. 35, 65-71 (2011
16. Rosenquist, K. J., et al. Visceral and subcutaneous fat quality and cardiometabolic risk. JACC Cardiovasc. Imaging 6, 762-771 (2013
17. Rosenquist, K. J., et al. Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. J. Clin. Endocrinol. Metab. 100, 227-234 (2015
18. Spencer, M., et al. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J. Clin. Endocrinol. Metab. 96, E1990-E1998 (2011
19. Parikh, N. I., et al. Increasing trends in incidence of overweight and obesity over 5 decades. Am. J. Med. 120, 242-250 (2007
20. Flegal, K. M., Carroll, M. D., Ogden, C. L., & Johnson, C. L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288, 1723-1727 (2002
21. Fox, C. S., et al. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. PLoS Genet. 8, e1002695 (2012
22. Fox, C. S., et al. Genome-wide association of pericardial fat identifies a unique locus for ectopic fat. PLoS Genet. 8, e1002705 (2012
23. Speliotes, E. K., et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7, e1001324 (2011
24. Foster, M. C., Yang, Q., Hwang, S. J., Hoffmann, U., & Fox, C. S. Heritability and genome-wide association analysis of renal sinus fat accumulation in the Framingham heart study. BMC Med. Genet. 12, 148 (2011
25. Locke, A. E., et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197-206 (2015
26. Berndt, S. I., et al. Genome-wide meta-Analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat. Genet. 45, 501-512 (2013
27. Shungin, D., et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187-196 (2015
28. Kannel, W. B., & McGee, D. L. Diabetes and cardiovascular disease. The Framingham Study. JAMA 241, 2035-2038 (1979
29. Kannel, W. B., Hjortland, M., & Castelli, W. P. Role of diabetes in congestive heart failure: the Framingham study. Am. J. Cardiol. 34, 29-34 (1974
30. Brand, F. N., Abbott, R. D., & Kannel, W. B. Diabetes, intermittent claudication, and risk of cardiovascular events: the Framingham Study. Diabetes 38, 504-509 (1989
31. Levitzky, Y. S., et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham heart study. J. Am. Coll. Cardiol. 51, 264-270 (2008
32. Huxley, R., Barzi, F., & Woodward, M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-Analysis of 37 prospective cohort studies. BMJ 332, 73-78 (2006
33. Fox, C. S., et al. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham heart study. Circulation 113, 2914-2918 (2006
34. Abraham, T. M., Pencina, K. M., Pencina, M. J., & Fox, C. S. Trends in diabetes incidence: the Framingham heart study. Diabetes Care 38, 482-487 (2015
35. Fox, C. S., et al. Trends in cardiovascular complications of diabetes. JAMA 292, 2495-2499 (2004
36. Fox, C. S., et al. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham heart study. Circulation 115, 1544-1550 (2007
37. Preis, S. R., et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham heart study, 1950 to 2005. Circulation 119, 1728-1735 (2009
38. Preis, S. R., et al. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham heart study. Circulation 120, 212-220 (2009
39. Wong, N. D., et al. Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status. Diab. Vasc. Dis. Res. 10, 505-513 (2013
40. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486-2497 (2001
41. Wilson, P. W., Dagostino, R. B., Parise, H., Sullivan, L., & Meigs, J. B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112, 3066-3072 (2005
42. Wilson, P. W., et al. Prediction of incident diabetes mellitus in middle-Aged adults: the Framingham Offspring Study. Arch. Intern. Med. 167, 1068-1074 (2007
43. Elias, P. K., et al. NIDDM and blood pressure as risk factors for poor cognitive performance: the Framingham Study. Diabetes Care 20, 1388-1395 (1997
44. Tuligenga, R. H., et al. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol. 2, 228-235 (2014
45. Tan, Z. S., et al. Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-Aged adults: the Framingham Offspring Study. Diabetes Care 34, 1766-1770 (2011
46. Meigs, J. B., Panhuysen, C. I., Myers, R. H., Wilson, P. W., & Cupples, L. A. A genome-wide scan for loci linked to plasma levels of glucose and HbA1c in a community-based sample of Caucasian pedigrees: the Framingham Offspring Study. Diabetes 51, 833-840 (2002
47. Dupuis, J., et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 42, 105-116 (2010
48. Meigs, J. B., et al. Genome-wide association with diabetes-related traits in the Framingham heart study. BMC Med. Genet. 8, S16 (2007
49. Prokopenko, I., et al. Variants in MTNR1B influence fasting glucose levels. Nat. Genet. 41, 77-81 (2009
50. Meigs, J. B., et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N. Engl. J. Med. 359, 2208-2219 (2008
51. Vassy, J. L., et al. Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 63, 2172-2182 (2014
52. Wang, T. J., et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17, 448-453 (2011
53. Floegel, A., et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62, 639-648 (2013
54. Walford, G. A., et al. Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. Diabetes Care 37, 2508-2514 (2014
55. Vernon, G., Baranova, A., & Younossi, Z. M. Systematic review: the epidemiology and natural history of non-Alcoholic fatty liver disease and non-Alcoholic steatohepatitis in adults. Aliment. Pharmacol. Ther. 34, 274-285 (2011
56. Loomba, R., et al. Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study. Gastroenterology 134, 953-959 (2008
57. Goessling, W., et al. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 135, 1935-1944 (2008
58. Porter, S. A., et al. Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham heart study. Arterioscler. Thromb. Vasc. Biol. 33, 139-146 (2013
59. Speliotes, E. K., et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham heart study. Hepatology 51, 1979-1987 (2010
60. Long, M. T., et al. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. Arterioscler. Thromb. Vasc. Biol. 35, 1284-1291 (2015
61. Long, M. T., et al. Hepatic steatosis is associated with lower levels of physical activity measured via accelerometry. Obesity (Silver Spring) 23, 1259-1266 (2015
62. Mellinger, J. L., et al. Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham heart study. J. Hepatol. 63, 470-476 (2015
63. Christakis, N. A., & Fowler, J. H. The spread of obesity in a large social network over 32 years. N. Engl. J. Med. 357, 370-379 (2007
64. Dawber, T. R., Moore, F. E., & Mann, G. V. Coronary heart disease in the Framingham study. Am. J. Publ. Health Nat. Health 47, 4-24 (1957
65. Kannel, W. B., Dawber, T. R., Kagan, A., Revotskie, N., & Stokes, J. 3rd Factors of risk in the development of coronary heart disease-six year follow-up experience: the Framingham Study. Ann. Intern. Med. 55, 33-50 (1961